Page 33 - Altrobiografie

Hemker, H. C., M. P. Esnouf, P. W. Hemker, A. C. Swart and R. G. Macfarlane (1967). "Formation of prothrombin converting activity." Nature 215(5098): 248-251.
Hemker, H. C., P. Giesen, R. Al Dieri, V. Regnault, E. de Smedt, R. Wagenvoord, T. Lecompte and S. Beguin (2003). "Calibrated automated thrombin generation measurement in clotting plasma." Pathophysiol Haemost Thromb 33(1): 4-15. Hemker, H. C., P. L. Giesen, M. Ramjee, R. Wagenvoord and S. Beguin (2000). "The thrombogram: monitoring thrombin generation in platelet-rich plasma." Thromb Haemost 83(4): 589-591.
Hemker, H. C., P. W. Hemker, K. v d Torren, P. P. Devilee, W. T. Hermens and E. A. Loeliger (1971). "The evaluation of the two-stage prothrombin assay." Thromb Diath Haemorrh 25(3): 545-554.
Hemker, H. C. and M. J. Kahn (1967). "Reaction sequence of blood coagulation." Nature 215(5106): 1201-1202.
Hemker, H. C., D. Menache and J.-P. Soulier (1964). "Specific activity of prothrombin." Abst. Fed. Eur. Biochem.Soc. Ist Symposion London: A62.
Hemker, H. C., A. D. Muller and E. A. Loeliger (1970). "Two types of prothrombin in vitamin K deficiency." Thromb Diath Haemorrh 23(3): 633-637.
Hemker, H. C., J. J. Veltkamp, A. Hensen and E. A. Loeliger (1963). "Nature of Prothrombin Biosynthesis: Preprothrombinaemia in Vitamin K-Deficiency." Nature 200: 589-590.
Hemker, H. C., S. Wielders, H. Kessels and S. Beguin (1993). "Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential." Thromb Haemost 70(4): 617-624.
Hemker, P. W., A. Miszta, W. T. Hermens and H. C. Hemker (2018). "Molecular Interaction and transport limitation in macromolecular binding to surfaces." bioRxiv: 380.337.
Hensen, A., F. Kroes, L. M. Van Dyck, N. Fekkes, H. C. Hemker and E. A. Loeliger (1966). "A double blind study of phenprocoumon prophylaxis after myocardial infarction." Thromb Diath Haemorrh Suppl 21: 333-336.
Hermens, W. T., G. M. Willems, K. M. Nijssen and M. L. Simoons (1992). "Effect of thrombolytic treatment delay on myocardial infarct size." Lancet 340(8830): 1297.
Hermens, W. T., S. A. Witteveen, L. Hollaar and H. C. Hemker (1975). "Effect of a thrombolytic agent (urokinase) on necrosis after acute myocardial infarction." Recent Adv Stud Cardiac Struct Metab 10: 319-329.
Hornstra, G. (1971). "The influence of dietary sunflowerseed oil and hardened coconut oil on intra-arterial occlusive thrombosis in rats." Nutr Metab 13(3): 140-149.
Josso, F. and O. Prou-Wartelle (1965). "Interaction of tissue factor and factor VII at the earliest phase of coagulation." Thromb Diath Haemorrh Suppl 17: 35-44.
Kruif, P. D. (1939). "Bacterienjagers." 5de druk H.P.Leopolds Uitgeverij.
Kumar, R., S. Beguin and H. C. Hemker (1994). "The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin." Thromb Haemost 72(5): 713-721.
Kumar, R., S. Beguin and H. C. Hemker (1995). "The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity." Thromb Haemost 74(3): 962-968.
Loeliger, E. A., A. Hensen, F. Kroes, L. M. van Dijk, N. Fekkes, H. de Jonge and H. C. Hemker (1967). "A double-blind trial of long-term anticoagulant treatment after myocardial infarction." Acta Med Scand 182(5): 549-566.
Loeliger, E. A., J. B. Meuwisse-Braun, H. Muis, F. J. Buitendijk, J. J. Veltkamp and H. C. Hemker (1970). "Laboratory control of oral anticoagulants. Definition of therapeutic range in terms of different thromboplastin preparations." Thromb Diath Haemorrh 23(3): 569-584.
Maan, A., R. Padmanabhan, A. Y. Shaikh, M. Mansour, J. N. Ruskin and E. K. Heist (2012). "Newer anticoagulants in cardiovascular disease: a systematic review of the literature." Cardiol Rev 20(5): 209-221.
Macfarlane, R. G. (1964). "An Enzyme Cascade in the Blood Clotting Mechanism, and Its Function as a Biochemical Amplifier." Nature 202: 498-499.
Macfarlane, R. G. and R. Biggs (1953). "A thrombin generation test; the application in haemophilia and thrombocytopenia." J Clin Pathol 6(1): 3-8.
Mammadova-Bach, E., V. Ollivier, S. Loyau, M. Schaff, B. Dumont, R. Favier, G. Freyburger, V. Latger-Cannard, B. Nieswandt, C. Gachet, P. H. Mangin and M. Jandrot-Perrus (2015). "Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation." Blood 126(5): 683-691.
Manzoor, B. S., T. A. Lee, L. K. Sharp, S. M. Walton, W. L. Galanter and E. A. Nutescu (2017). "Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation." Pharmacotherapy 37(10): 1221-1230.
Nesheim, M. E., J. B. Taswell and K. G. Mann (1979). "The contribution of bovine Factor V and Factor Va to the activity of prothrombinase." J Biol Chem 254(21): 10952-10962.
Nimpf, J., E. M. Bevers, P. H. Bomans, U. Till, H. Wurm, G. M. Kostner and R. F. Zwaal (1986). "Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I." Biochim Biophys Acta 884(1): 142-149.
NN (2019). "Farmaceuten betalen fors in schikking bloedverdunner." NRC-Handelsblad.
Providencia, R., E. L. Grove, S. Husted, S. Barra, S. Boveda and J. Morais (2014). "A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens." Thromb Res 134(6): 1253-1264.
Reutelingsperger, C. P., J. M. Kop, G. Hornstra and H. C. Hemker (1988). "Purification and characterization of a novel protein from bovine aorta that inhibits coagulation. Inhibition of the phospholipid-dependent factor-Xa-catalyzed prothrombin activation, through a high-affinity binding of the anticoagulant to the phospholipids." Eur J Biochem 173(1): 171-178. Rosing, J., G. Tans, J. W. Govers-Riemslag, R. F. Zwaal and H. C. Hemker (1980). "The role of phospholipids and factor Va in the prothrombinase complex." J Biol Chem 255(1): 274-283.
33